News and Announcements
Arthritis Relief Plus Annual Update 2016; US FDA Compliance Completed, Australian Government Support & First Commercial Batch in US
- Published January 17, 2017 5:08PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Arthritis Relief Plus Ltd (ARP) attained countless achievements during 2016.
- The company managed to complete US FDA compliance, securing an OTC topical drug status/ classification for 4Jointz.
- With also securing Australian Government support in the first cohort at the Rocketspace LandingPad in San Francisco.
- ARP also were awarded the Queensland Government Ignite grant, with commencing production of the first commercial batch of 4 Jointz in the USA.
- ARP also received to its advantage, national and regional broadcasting news coverage of its product throughout Australia.
- Finally, ARP secured a new investment offer which opened to fund the USA market growth and prepare for the global market partnering/licensing activities.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
